2014 marked an extraordinary year for regenerative medicine and for CIRM. We welcomed a new president, several of our research programs have moved into clinical trials—and our goal of accelerating treatments for patients in need is within our grasp. As we look back we’d like to revisit The Stem Cellar’s ten most popular stories of … Continue reading Stem Cell Stories that Caught Your Eye: The Most Popular Stem Cellar Stories of 2014
Industry News
At World Stem Cell Summit improvements in the precision with which we can edit our genes grabs spotlight
Just a day and a half into this year’s World Stem Cell Summit in San Antonio and there have been numerous highlights. But a pair of sessions on gene editing grabbed the attention of many of the scientists at the meeting. One of the renown leaders in the field, Harvard’s George Church wowed the scientists, … Continue reading At World Stem Cell Summit improvements in the precision with which we can edit our genes grabs spotlight
Truth or Consequences: how to spot a liar and what to do once you catch them
Nothing undermines the credibility of science and scientists more than the retraction a high profile paper. Earlier this year there was a prime example of that when researchers at one of Japan’s most prestigious research institutions, the Riken Center for Developmental Biology in Kobe, had to retract a study that had gathered worldwide attention. The … Continue reading Truth or Consequences: how to spot a liar and what to do once you catch them
Taking Promising Therapies out of the Lab and into People: Tips from Experts at the World Stem Cell Summit on How to Succeed
Having a great idea for a stem cell therapy is the easy part. Getting it to work in the lab is tougher. But sometimes the toughest part of all is getting it out of the lab and into clinical trials in patients. That’s natural and sensible, after all we need to make sure that something … Continue reading Taking Promising Therapies out of the Lab and into People: Tips from Experts at the World Stem Cell Summit on How to Succeed
At World Stem Cell Summit: Why results in trials repairing hearts are so uneven
Just as no two people are the same, neither are the cells in their bone marrow, the most common source of stem cells in clinical trials trying to repair damage after a heart attack. Doris Taylor of the Texas Heart Institute in Houston, which is just a couple hours drive from the site of this … Continue reading At World Stem Cell Summit: Why results in trials repairing hearts are so uneven
Searching for a Cure for HIV/AIDS: Stem Cells and World AIDS Day
It's been 26 years since the first World AIDS Day was held in 1988—and the progress that the international scientific community has made towards eradicating the disease has been unparalleled. But there is much more work to be done. One of the most promising areas of HIV/AIDS research has been in the field of regenerative … Continue reading Searching for a Cure for HIV/AIDS: Stem Cells and World AIDS Day
10 Years/10 Therapies: 10 Years after its Founding CIRM will have 10 Therapies Approved for Clinical Trials
In 2004, when 59 percent of California voters approved the creation of CIRM, our state embarked on an unprecedented experiment: providing concentrated funding to a new, promising area of research. The goal: accelerate the process of getting therapies to patients, especially those with unmet medical needs. Having 10 potential treatments expected to be approved for … Continue reading 10 Years/10 Therapies: 10 Years after its Founding CIRM will have 10 Therapies Approved for Clinical Trials
UCLA team cures infants of often-fatal “bubble baby” disease by inserting gene in their stem cells; sickle cell disease is next target
Poopy diapers, ear-splitting cries, and sleepless nights: sure, the first few weeks of parenthood are grueling but those other moments of cuddling and kissing your little baby are pure bliss. That wasn’t the case for Alysia and Christian Padilla-Vacarro of Corona, California. Close contact with their infant daughter Evangelina, born in 2012, was off limits. … Continue reading UCLA team cures infants of often-fatal “bubble baby” disease by inserting gene in their stem cells; sickle cell disease is next target
Entrepreneurship and Education
Guest author Neil Littman is CIRM's Business Development Officer. CIRM works closely with UCSF on a number of initiatives, from providing funding to academic investigators to jointly hosting events such as the recent CIRM Showcase with J-Labs held at the Mission Bay campus. Beyond our joint initiatives, UCSF also provides many other valuable resources and … Continue reading Entrepreneurship and Education
Ideas and Energy Reveal Surprises at Stem Cell Showcase
Janssen, the company within the pharmaceutical giant Johnson & Johnson responsible for much of its research and development, has a branch in the Bay Area called J Labs. It seeks to foster innovation in all sectors of biomedical research. One piece of that effort brings together innovators for monthly gatherings to exchange ideas and network. … Continue reading Ideas and Energy Reveal Surprises at Stem Cell Showcase
The Stem Cellar 